Menu

Editas Medicine, Inc. EDIT

Full chart Compare
Set alert

Price alert · EDIT

All alert types
2.57 USD +0.02 (+0.78%)

At closeNov 6, 2026, 6:37 PM EST

2.57 0.00 0.00%

After hours · Nov 6, 6:37 PM ET

2.48 Day range 2.63
1.66 52-week range 3.75
YTD
+25.37%
1 year
-4.46%

Discussion (212)

Sign in to join the discussion

Vivian O'Neal EDIT 6 years ago #71

Good presentation this morning Chief scientific officer feels the market is currently undervaluing the company. FYI a company called ProQR also is in trials with gene therapy for lca10. Editas’s study is best in class as if effectively produces more receptors permanently. Lastly he felt that the oncology studies are flying under the radar as well in regards to their approach/progress. They are still on track for adult mid dose cohort that should come along with data updates this year.

Vivian O'Neal EDIT 6 years ago #75

If you know stocks you know this is ripe for a reversal. The money will and always comes back when institutional ownership is this high. Patience they will move it .

Vivian O'Neal EDIT 6 years ago #77

HOLD DO NOT LET THEM SHAKE YOU LOT IF ADJUSTING FOR FUNDS THIS MONTH

Vivian O'Neal EDIT 6 years ago #78

This is actually what’s needed down here in order to reverse trend and break out to the upside

Vivian O'Neal EDIT 6 years ago #79

Peloton gets a 30bil evaluation for a bike/platform that keeps you healthy. EDIT,CRSP,BEAM & NTLA get 10Bil combined for longer lives, restoring vision and curing diseases. Go figure. The market is literally behind itself. It feels awesome to be before the curve. This is like buying NFLX in 2013.

Vivian O'Neal EDIT 6 years ago #80

Saw that it is our season meaning biotech. Typically rally October-January